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The nature of y-aminobutyric acid (GABA) transport has been investigated in preparations of rat brain 
synaptosomes using a number of thiol reagents with varying membrane permeabilities. N-Ethylmaleimide, 
p-chloromercuribenzoate nd p-chloromercuriphenylsulfonate effectively inhibited GABA transport in 
both directions (i.e., uptake and release) whereas 5,5’-dithiobis-2-nitrobenzoate, mercaptopropionate nd 
N-nitroethylenediamine were much less effective, or ineffective, even at millimolar concentrations. For 
each of the thiol reagents, the inhibition profile for GABA uptake was approximately the same as that 
for its release. The effectiveness of the reagents indicates that there is an external, reactable SH-group on 
the transporter, that the thiol reagent must be somewhat lipophilic for it to react with the SH-group(s), 
and that the same synaptosomal transport system is responsible for both uptake and release of GABA. 
Synaptosome y-Aminobutyric acid 
1. INTRODUCTION 
It is generally agreed that y-aminobutyric acid 
(GABA) is one of the primary inhibitory 
nemotransmitters in the mammalian central ner- 
vous system [l-3]. Experiments have indicated 
that GABA may function at up to 50% of the 
synapses in the brain, depending on the region in- 
vestigated [4-81. The properties of GABA uptake 
have been studied extensively in brain slices and 
isolated nerve endings (synaptosomes). Two 
systems for the neuronal accumulation of 
radiolabeled GABA have been demonstrated, one 
with a relatively high affinity, a K, value of 
2-lOpM, and the other with a relatively low af- 
finity, a K, value of approx. 1 mM [9-121. The 
high affinity uptake system is almost exclusively 
neuronal and is dependent on the presence of 
sodium [13,14]. In preparations of isolated brain 
synaptosomes it has been demonstrated that two 
sodium ions accompany the movement of one 
GABA molecule from outside to inside and that 
the energy utilized for this transport is provided by 
a combination of the sodium concentration gra- 
dient, [Na+],/[Na+]r, and the transmembrane lec- 
trical potential [ 151. 
Depolarization with high external potassium 
concentrations or veratrine alkaloids results in the 
release of GABA. A number of studies have shown 
that the stimulus-secretion coupled release of 
GABA has a substantial calcium-independent 
component [ 13,16- 191. These observations have 
led to the suggestion that neuronal membranes 
possess a reversible sodium-dependent transport 
system which may be responsible for both GABA 
uptake and release [13,18]. One method of testing 
the symmetry suggested by this hypothesis is to use 
a non-competitive inhibitor of GABA uptake and 
observe its effect on stimulus-secretion coupled 
GABA release. If the membrane transport system 
is symmetric, one would expect a non-competitive 
inhibitor of GABA influx to have the same or a 
parallel effect on GABA efflux. 
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reagents on the transport of GABA across synap- 
tosomal membranes i olated from rat brains. Thiol 
reagents were chosen for study because they are 
known to be potent non-competitive inhibitors of 
GABA uptake [20]. The data provide evidence that 
GABA uptake and release utilize a reversible 
transport system. 
2. MATERIALS AND METHODS 
Synaptosomes were isolated from the cortex and 
midbrain of 200-250 g, male Sprague-Dawley rats 
as in [21]. The synaptosomes were suspended in a 
Krebs-Henseleit-Hepes buffer (140 mM NaCl, 
5 mM KCl, 10 mM Tris-Hepes 5 mM NaHC% 
1.3 mM MgS04 and 1 mM NaHP04 (PI-I 7.4) at 
about 7 mg protein/ml. All incubations were done 
at 27°C and were supplemented with 2.5 mM 
CaC12 and 10 mM glucose. Protein concentration 
was determined as in [22] using bovine serum 
albumin as the standard. 
2.1. Measurements of GABA uptake and steady 
state gradients 
After preincubating the synaptosomes for 5 min 
a thiol reagent was added and incubation con- 
tinued for 5 more min. The synaptosomes were 
diluted 5-fold into the same buffer containing 
1.2 PM [14C]GABA (New England Nuclear). Ali- 
quots (200 or 300 ~1) were withdrawn, rapidly cen- 
trifuged and radioactivity measured as in [16]. 
Maximal (steady state) GABA gradients were 
measured by removing aliquots 15 min after ‘the 
5-fold dilution of synaptosomes after ascertaining 
that the maximal gradient had been attained. 
2.2. Measurements of GABA release 
Synaptosomes were preincubated with 1.25 or 
2.5 PM [14C]GABA plus 2 mM amino-oxyacetic 
acid for lo-15 min. Thiol reagents were then add- 
ed and incubation continued 5 min. The synap- 
tosomes were diluted lo-fold into either the same 
buffer as described above or a depolarizing Krebs- 
Henseleit-Hepes buffer containing 40 mM KC1 
plus 60pM veratridine. Aliquots (200 or 300 ~1) 
were withdrawn and handled as described above. 
The initial rates of depolarized release were 
calculated by linear regression analysis of the 
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measured radioactivity of both supernatant and 
pellet fractions. 
2.3. Measurements of intrasynaptosomal water 
Synaptosomes were preincubated, thiol reagent 
was added and incubation continued for 5 min. 
After diluting the synaptosomes 5-fold into non- 
depolarizing Krebs-Henseleit-Hepes buffer and 
incubating lo- 15 min, intrasynaptosomal water 
was measured as in [16]. 
2.4. Measurements of membrane potential 
Synaptosomes were incubated in the presence or 
absence of thiol reagent, as described above, 
diluted 5-fold with non-depolarizing Krebs- 
Henseleit-Hepes buffer, and further incubated 
lo-15 min. The transmembrane lectrical poten- 
tials were calculated from the steady state distribu- 
tion of potassium as in [ 161. 
2.5. Measurements of oxygen consumption 
Synaptosomes were preincubated 5 min, thiol 
reagents were added and incubation continued 
5 min, and the rates of oxygen consumption were 
measured with a Clark-type oxygen electrode at 
25°C. 
2.6. Reversal of the effects of 
p-chloromercuribenzoate 
2.6.1. GABA uptake and steady state gradients 
Synaptosomes were incubated with p- 
chloromercuribenzoate (PCMB) for 5 min. The 
synaptosomes were then diluted 5-fold into non- 
depolarizing buffer containing mercaptoethanol, 
at 1.5 times the final concentration of the thiol 
reagent, and incubation was continued for 5 more 
min. [14C]GABA was added to the incubation mix- 
ture and uptake and steady state gradient 
measurements were made as described above. 
2.6.2. GABA release 
Synaptosomes were loaded with [14C]GABA and 
treated with PCMB for 5 min as described. Mer- 
captoethanol, at 1.5 times the PCMB concentra- 
tion, was added and incubation continued for 5 
more min. The synaptosomes were then diluted 
lo-fold into either depolarizing or non- 
depolarizing buffer and aliquots were withdrawn 
and treated as described above. 
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3. RESULTS 
3.1. The effect of thiol reagents on GABA uptake 
and release 
Fig.1 shows the effects of various SH-reagents 
on GABA uptake and release. PCMB and p- 
chloromercuriphenylsulfonate (PCMS) were 
equally effective at inhibiting GABA transport 
with ICsc values for both influx and efflux of 
about 200 FM. N-Ethylmaleimide (NEM) was 
somewhat less effective as an inhibitor, with an 
~CSO for transport in both directions across the 
synaptosomal membrane of 5OO/cM. 5,5’-Dithio- 
bis-2-nitrobenzoate (DTNB) at the maximal con- 
A 
N-ethylmoleimide (mM) 
p-chloromercuriphenylsulfonote (mM) 
centration utilized (1 mM) decreased GABA 
transport only 2040%. Mercaptopropionate and 
N-nitroethylenediamine, the two least lipophilic 
agents used, were ineffective, even at millimolar 
concentrations (not shown). 
It was noted that the small efflux of ac- 
cumulated [i4C]GABA which is usually observed 
in synaptosomes diluted into non-depolarizing 
media was increased to varying degrees by in- 
cubating with thiol reagents. At the KSO values for 
inhibition of GABA transport PCMB caused no 
significant increase in this efflux whereas PCMS 
stimulated it 2-fold. At higher concentrations both 
compounds stimulated the rate of efflux of the ac- 
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Fig.1. The effect of thiol reagents on GABA uptake and release. Synaptosomes were suspended to a protein 
concentration of about 7 mg/ml in Krebs-Henseleit-Hepes buffer (pH 7.4). After preincubating the synaptosomes, 
thiol reagents were added and incubation was continued for 5 min. The reaction mixtures were again diluted S-fold for 
uptake experiments. Aliquots (200 or 300 ~1) were rapidly centrifuged through silicone oil 30,60,90, 120 and 180 s after 
either the addition of 1.2 pM [14C]GABA (uptake) or diluting synaptosomes lo-fold into depolarizing or normal Krebs- 
Henseleit-Hepes buffer (release). See section 2 for details. Each point represents the mean % of control f SE for 
individual experiments with n values as follows: (A) N-ethylmaleimide-uptake, 3, release, 6; (B) p- 
chloromercuribenzoate-uptake, 15, release, 14; (C) p-chloromercuriphenylsulfonate-uptake, 2, release, 4; (D) 
5,5’-dithiobis-2-nitrobenzoate-uptake, 3  release, 4. The mean control value for uptake is 232.75 f 16.44 pmol/mg 
protein per min. 
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cumulated amino acid. NEM in the range of 
250-5OOpM increased GABA leakage by about 
50%, and 1.5fold at 1 mM. DTNB appeared to 
have no significant effect at the concentrations 
utilized. Because the effects of thiol reagents on 
stimulation-secretion coupled release were of par- 
ticular interest, the values for depolarized release 
presented in fig.1 were corrected for that not due 
to depolarization of the synaptosomes, i.e., the ef- 
flux which occurred upon dilution into non- 
depolarizing media. 
seen that, of the agents tested, only NEM pro- 
duced a significant inhibition of oxygen consump- 
tion. The other compounds did not affect O2 
uptake in the concentration range employed. 
3.3. The effect of PCMB and PCMS on 
synaptosomal membrane potential and the 
maximal GABA gradient 
The effects of PCMB and PCMS on the 
3.2. The effect of thiol reagents on synaptosomal 
respiration 
The effect of various thiol reagents on synap- 
tosomal respiration is illustrated in fig.2. It can be 
I OXYGEN CONSUMPTION 
transmembrane lectrical potential and maximal 
GABA gradients were investigated in order to 
establish whether the inhibition of uptake was due 
to a decrease in the driving forces for GABA ac- 
cumulation [13- 151. It can be seen (table 1) that 
the ZCSO concentration of PCMB had no signifi- 
cant effect on the membrane potential. At 250 ,uM, 
this compound decreased the steady-state GABA 
gradient from approx. 600 to 400, without much 
change in the electrical potential. Both the mem- 
brane potential and the [GABA]i/[GABA]. were 
decreased at 500/1M PCMB. 
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Fig.2. The effect of thiol reagents on synaptosomal 
respiration. Synaptosomes were suspended in Krebs- 
Henseleit-Hepes buffer to a final concentration of 
about 7 mg protein/ml, and preincubated for 5 min. 
Thiol reagents were then added and the rates of oxygen 
consumption were measured with a Clark-type oxygen 
electrode at 25°C. The values are the means of 3 
experiments f SE. Thep-values from the Student’s t-test 
are indicated. 
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PCMS caused a slightly greater depolarization 
of synaptosomes and a more pronounced decrease 
in the maximal GABA gradient than did PCMB. 
The larger decrease in the maximal GABA 
equilibrium gradient with PCMS as compared to 
PCMB may have been caused by higher non- 
specific leakage of the amino acid induced by the 
former compound. 
Neither PCMS nor PCMB had any effect on the 
sodium gradient when measured by atomic absorp- 
tion or by the equilibrium distribution of 22Na (not 
shown). 
3.4. Reversibility of the effects of PCMB 
The reversibility of the effects of PCMB was 
studied using mercaptoethanol at concentrations 
1.5 times greater than the PCMB concentration 
utilized. Fig.3 shows that after treating the synap- 
tosomes with 250 ,uM PCMB, mercaptoethanol 
was able to fully restore GABA transport. The 
steady state GABA gradient was also returned to 
its original value, within the limits of experimental 
error. At 500pM PCMB, GABA uptake and 
release were restored to about 75% of their respec- 
tive controls and [GABA]i/[GABA], to 500 + 24 
(i.e., somewhat lower than control, table 1). Mer- 
captoethanol alone had no significant effect on 
either GABA transport or the steady state GABA 
gradient. 
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Table 1 
Effect of p-chloromercuribenzoate and p-chloromercuriphenylsulfonate on transmembrane electrical potential and 
GABA gradient 
Concentration Membrane potential GABA gradient 
(uM) (mV) (i/o) 
PCMB PCMS PCMB PCMS 
0 54.8 f 2.0 54.8 i 2.0 594.0 f 59.2 594.0 + 59.2 
100 52.8 * 3.4 SO.6 + 7.9 589.6 f 62.9 640.0 & 203.6 
200 53.8 + 2.2 53.2 + 9.2 478.4 f 55.0 179.5 + lS.Sb 
250 52.1 + 2.4 48.1 + 9.0 389.7 + 42.3b 121.2 + ls.sc 
500 46.1 + 3.1’ 38.9 f 9.gb 98.3 f 3.1e 26.8 + 7.5* 
ap < 0.050 
b p < 0.025 
c p < 0.010 
*p<o.OOs 
’ p c 0.001 (Student’s tltest) 
Synaptosomes were suspended in Krebs-Henseleit-Hepes buffer, preincubated, and incubated with PCMB or PCMS 
as described. The synaptosomes were then diluted 3-fold into buffer with (for determining the GABA gradient) or 
without (for the potassium distribution measurement) 1FM [‘*C]GABA plus 2 pM amino-oxya~tic acid and allowed 
to equilibrate for 15 min. Aliquots (200 or 300 ~1) were withdrawn and handled as described in section 2. The n values 
for PCMB and PCMS were 7 and 2, respectively 
T, 80- 
k 
3 60- 
$ 
40- 
250pM PCMB 500 /LM PCMB 
Uptake Release Uptake Release 
Fig.3. The reversibility of the effect of p-chloromercuri- 
benzoate on GABA transport. Synaptosomes were sus- 
pended in Krebs-Henseleit-Hepes buffer, preincubated 
and incubated for 5 min with PCMB as described above. 
The effects of the thiol reagent were reversed by 
incubating the synaptosomes with 1.5 times the final 
PCMB concentration for 5 min. See section 2 for 
details. The values are the means of the (70 of control it 
SE for each of the 3 uptake and 4 release experiments. 
(a) MercaptoethanoI, (b) PCMB, (c) PCMB plus mer- 
captoethanol. * p < 0.025, ** p < 0.010, *** p < 0.005, 
g$ p < 0.001 (Student’s t-test). 
4. DISCUSSION 
The results presented here show that thiol 
reagents are effective inhibitors of GABA 
transport. The effectiveness of these compounds in 
interfering with the transport of the amino acid 
depended, to a certain degree, on their lipophilici- 
ty. The ability of DTNB, PCMB, and PCMS, 
reagents which are only partially membrane- 
permeable, to successfully block GABA uptake 
and release indicates that the reactive SH-group(s) 
on the transport protein is oriented toward the ex- 
ternal surface of the plasma membrane. On the 
other hand, the fact that the least lipophilic 
reagents, mercaptopropionate and N-nitroethyl- 
enediamine, were ineffective suggests that the SH- 
group(s) is not completely exposed to the external 
milieu but is likely to be buried within a hydro- 
phobic part of the transporter. 
furthermore, our results demonstrate that all 
the thiol reagents which inhibited GABA uptake 
also blocked the amino acid’s release, and the ex- 
tent to which the two processes were decreased was 
approximately the same. This pattern of effec- 
tiveness indicates that the GABA transporter of 
synaptosomes mediates both the influx and 
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depolarization-stimulated efflux of this amino 
acid. 
The most effective inhibitors of GABA 
transport were PCMB and PCMS which at their 
ZCSO values affect neither synaptosomal respiration 
nor the transmembrane electrical potential or 
sodium concentration gradient. By contrast, NEM 
at its ZCSO for GABA transport also caused a 
decrease in synaptosomal respiration, in agreement 
with the known sensitivity of mitochondria to this 
reagent [23]. It should be pointed out that a 
decrease in respiration and the consequent reduc- 
tion in ATP synthesis would ultimately lead to an 
influx of Na+ and membrane depolarization (i.e., 
it would decrease the driving forces for GABA ac- 
cumulation). However, a decrease in the driving 
forces for GABA accumulation would be expected 
to result in a decline in the uptake and a stimula- 
tion of the release of the amino acid neurotrans- 
mitter. Hence, the effect of NEM on GABA trans- 
port seen in this work is not likely to be due only 
to an indirect action through energy depletion but 
rather appears to be a combination of its effect on 
transport and on mitochondrial function. 
The ZCSO values for the effective SH-group 
reagents were in the range of 200-500pM which, 
at the protein concentration utilized here, cor- 
responds to 30-70 nmol/mg protein. These figures 
compare with studies on the mitochondrial 
transport system which is inhibited by 50% at 
a concentration of thiol reagents between 
lo-50 nmol/mg protein [23]. 
It is also worth mentioning that higher concen- 
trations of both PCMB and PCMS affect other 
synaptosomal functions: they increase non-specific 
leakage of GABA and decrease the transmembrane 
electrical potential. Although the mechanism(s) 
which is responsible for the latter changes is not 
clear at the present time, this observation is not 
unexpected because the thiol reagents are non- 
specific in that they can react with any accessible 
SH-group and modify many related functions. 
The extrapolation of our in vitro findings to in 
vivo situations is difficult. In in vitro studies of 
isolated synaptosomes, the release of GABA ap- 
pears to occur from the cytosolic compartment 
[24] and contains a large calcium-insensitive com- 
ponent. Thus, in our experimental system, 
vesicular release of GABA, if it exists, contributes 
negligibly to the observed pattern of release of this 
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amino acid. If the in vitro model is valid, there ex- 
ists in vivo a substantial non-vesicular component 
for the depolarization-stimulated release of GABA 
which occurs via reversal of the membrane poten- 
tial and Na-dependent ransport system. 
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